Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
- PMID: 34947815
- PMCID: PMC8703281
- DOI: 10.3390/life11121284
Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
Abstract
The current serological test for human onchocerciasis relies on IgG4 reactivity against the parasite Ov-16 antigen, with reported sensitivities of only 60-80%. As control programs move from control to elimination, it is imperative to identify novel molecules that could improve the serodiagnosis reliability of this disease. In this study we compared the sensitivity of total IgG against OvMANE1-a chimeric antigen previously identified as a potential biomarker of human onchocerciasis-with that of an Ov-16 antibody test to detect an Onchocerca volvulus infection in persons presenting with microfilaria in skin snips. One hundred and ninety serum samples were obtained from persons with epilepsy in an onchocerciasis-endemic area at Ituri in the Democratic Republic of Congo where ivermectin has never been distributed. Fifty-nine (31.1%) samples were from individuals with a positive skin snip test; 41 (69.5%) of these 59 samples were positive with the OvMANE1 test and 41 (69.5%) with the Ov-16 test; 30 (50.8%) samples were positive for both tests and in 52 (88.1%) at least one of the tests was positive. Testing the 131 sera from persons with a negative skin snip result revealed that 63 (48.1%) were positive exclusively with the OvMANE1 test, 13 (9.9%) exclusively with the Ov-16 test and 25 (19.1%) with both tests. Nine European samples from individuals without past travel history in onchocerciasis endemic zones and 15 samples from Rwanda, a hypoendemic country for onchocerciasis were all negative for the OvMANE1 and Ov-16 tests. However, the specificity of both tests was difficult to determine due to the lack of a gold standard for antibody tests. In conclusion, the tandem use of OvMANE1 and Ov-16 tests improves the sensitivity of detecting Onchocerca volvulus seropositive individuals but, the OvMANE1 test needs to be further evaluated on samples from a population infected with other helminths to cautiously address its specificity.
Keywords: ELISA; Onchocerca volvulus; Ov-16; OvMANE1; antibodies; diagnostic; sensitivity.
Conflict of interest statement
The authors declare no conflict of interest and testify that these data are not submitted for publication elsewhere in another journal.
Figures
Similar articles
-
In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.Pathogens. 2020 Jun 22;9(6):495. doi: 10.3390/pathogens9060495. Pathogens. 2020. PMID: 32580355 Free PMC article.
-
Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo.Pathogens. 2020 Jun 2;9(6):435. doi: 10.3390/pathogens9060435. Pathogens. 2020. PMID: 32498284 Free PMC article.
-
Comparison of PCR Methods for Onchocerca volvulus Detection in Skin Snip Biopsies from the Tshopo Province, Democratic Republic of the Congo.Am J Trop Med Hyg. 2018 May;98(5):1427-1434. doi: 10.4269/ajtmh.17-0809. Epub 2018 Mar 29. Am J Trop Med Hyg. 2018. PMID: 29611501 Free PMC article.
-
Assessment and monitoring of onchocerciasis in Latin America.Adv Parasitol. 2011;77:175-226. doi: 10.1016/B978-0-12-391429-3.00008-3. Adv Parasitol. 2011. PMID: 22137585 Review.
-
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.Cochrane Database Syst Rev. 2016 Jan 15;2016(1):CD011146. doi: 10.1002/14651858.CD011146.pub2. Cochrane Database Syst Rev. 2016. PMID: 26771164 Free PMC article. Review.
Cited by
-
Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring.Diagnostics (Basel). 2022 Jun 11;12(6):1440. doi: 10.3390/diagnostics12061440. Diagnostics (Basel). 2022. PMID: 35741250 Free PMC article.
References
-
- Shintouo C.M., Nguve J.E., Asa F.B., Shey R.A., Kamga J., Souopgui J., Ghogomu S.M., Njemini R. Entomological Assessment of Onchocerca Species Transmission by Black Flies in Selected Communities in the West Region of Cameroon. Pathogens. 2020;9:722. doi: 10.3390/pathogens9090722. - DOI - PMC - PubMed
-
- World Health Organisation Onchocerciasis Key Facts. [(accessed on 27 September 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/onchocerciasis.
-
- Vinkeles Melchers N.V.S., Mollenkopf S., Colebunders R., Edlinger M., Coffeng L.E., Irani J., Zola T., Siewe J.N., de Vlas S.J., Winkler A.S., et al. Burden of onchocerciasis-associated epilepsy: First estimates and research priorities. Infect. Dis. Poverty. 2018;7:101. doi: 10.1186/s40249-018-0481-9. - DOI - PMC - PubMed
-
- Colebunders R., Njamnshi A.K., van Oijen M., Mukendi D., Kashama J.M., Mandro M., Gumisiriza N., Preux P.-M., Suykerbuyk P., Idro R. Onchocerciasis-associated epilepsy: From recent epidemiological and clinical findings to policy implications. Epilepsia Open. 2017;2:145–152. doi: 10.1002/epi4.12054. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
